Samarth Kulkarni - Insider Trading & Ownership

Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Samarth Kulkarni is at least $22.8M dollars as of October 20, 2025. Samarth Kulkarni is the Chief Executive Officer, Director of CRISPR Therapeutics AG and owns shares of CRISPR Therapeutics AG (CRSP) stock worth about $22.8M.
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Samarth Kulkarni

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRSP CRISPR Therapeutics AG Chief Executive Officer, Director $22.8M -$8.38M -26.9% Oct 16, 2025
BDTX Black Diamond Therapeutics, Inc. Director Jun 12, 2025
CNTA Centessa Pharmaceuticals plc Director Jun 20, 2025
ORKA Oruka Therapeutics, Inc. Director Jun 2, 2025
RPTX Repare Therapeutics Inc. Director Jun 17, 2024

Insider Transactions Reported by Samarth Kulkarni:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.